Clinical Trial Update: RECOMMEND Platform Trial [Phase 3]

View source ↗

Summary

Phase 3 RECOMMEND Platform Trial is not yet recruiting and will assess interventions across ARDS, ECMO complication, cardiac arrest, and other critical illness …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Respiratory Distress Syndrome

Snippet

Sponsor: Australian and New Zealand Intensive Care Research Centre | Conditions: Extracorporeal Membrane Oxygenation Complication, ARDS (Acute Respiratory Distress Syndrome) | Phase 3 | Status: NOT_YET_RECRUITING